C. Difficile

>

Latest News

Impact of Live Biotherapeutic Products on Gut Microbiome in Recurrent C difficile Infections
Impact of Live Biotherapeutic Products on Gut Microbiome in Recurrent C difficile Infections

June 11th 2024

Presented at DDW 2024 by Ken Blount, the effectiveness of live biotherapeutic products in treating recurrent C difficile infections (rCDI), offering insights into microbiota alteration and prospects for management.

Insights and Implications on the Impact of Reduced Vancomycin Susceptibility in Clostridioides difficile
Insights and Implications on the Impact of Reduced Vancomycin Susceptibility in Clostridioides difficile

May 30th 2024

VE303 Potential to Relief to Those Impacted by Recurrent Clostridioides difficile Infection
VE303 Potential to Relief to Those Impacted by Recurrent Clostridioides difficile Infection

May 25th 2024

Top Infectious Disease News Stories May 17- May 24
Top Infectious Disease News Stories May 17- May 24

May 24th 2024

Shortened Treatment Regimen Resolves C difficile Infection
Shortened Treatment Regimen Resolves C difficile Infection

May 12th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.